In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-443V
Filed: March 7, 2017
Not for Publication
*************************************
CHRISTIAN GEIDEMANN and ERINN *
GEIDEMANN, on behalf of their Minor *
Daughter H.G.G., *
*
* Attorneys’ fees and costs decision;
Petitioners, * reasonable attorneys’ fees and costs
*
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
*************************************
Michael A. Firestone, San Mateo, CA, for petitioners.
Ann D. Martin, Washington, DC, for respondent.
MILLMAN, Special Master
DECISION AWARDING ATTORNEYS’ FEES AND COSTS 1
On April 7, 2016, petitioners filed a petition for compensation under the National
Childhood Vaccine Injury Act, 42 U.S.C. §§ 300aa-10–34 (2012). Petitioners alleged that their
daughter’s April 3, 2013 receipt of the diphtheria-tetanus toxoid-acellular pertussis (“DTaP”)
vaccine and/or measles-mumps-rubella (“MMR”) vaccine caused her to develop pediatric acute
neuropsychiatric syndrome (“PANS”). On October 25, 2016, the undersigned issued an Order
Concluding Proceedings.
On February 20, 2017, petitioners filed a motion for attorneys’ fees and costs, requesting
1
Because this unpublished decision contains a reasoned explanation for the special master’s action in this
case, the special master intends to post this unpublished decision on the United States Court of Federal
Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012)
(Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that
all decisions of the special masters will be made available to the public unless they contain trade secrets
or commercial or financial information that is privileged and confidential, or medical or similar
information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a
decision is filed, petitioner has 14 days to identify and move to redact such information prior to the
document=s disclosure. If the special master, upon review, agrees that the identified material fits within
the banned categories listed above, the special master shall redact such material from public access.
attorneys’ fees of $16,358.24, attorneys’ costs of $950.79, and personal costs of $550.00, for a
total request of $17,859.03.
On March 7, 2017 respondent filed a response to petitioners’ motion explaining that he is
satisfied this case meets the statutory requirements for an award of attorneys’ fees and costs
under 42 U.S.C. § 300aa-15(e)(1)(A)-(B). Resp. at 2. Respondent “respectfully recommends
that the [undersigned] exercise her discretion and determine a reasonable award for attorneys’
fees and costs.” Id. at 3.
The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.”
42 U.S.C. § 300aa-15(e)(1). It is not necessary for a petitioner to prevail in the case-in-chief in
order to receive a fee award as long as petitioner brought the claim in “good faith and there was a
reasonable basis for the claim.” Id. The special master has “wide discretion in determining the
reasonableness” of attorneys’ fees and costs. Perreira v. Sec’y of HHS, 27 Fed. Cl. 29, 34
(1992), aff’d, 33 F.3d 1375 (Fed. Cir. 1994); see also Saxton ex rel. Saxton v. Sec’y of HHS, 3
F.3d 1517, 1519 (Fed. Cir. 1993) (“Vaccine program special masters are also entitled to use their
prior experience in reviewing fee applications.”).
Based on her experience and review of the billing records submitted by petitioners, the
undersigned finds that petitioners’ attorneys’ fees and costs request is reasonable. Therefore,
the undersigned GRANTS petitioners’ Motion for Attorneys’ Fees and Costs. Accordingly,
the court awards:
a. $17,309.03, representing attorneys’ fees and costs. The award shall be in the form of
a check made payable jointly to petitioners and Marvin Firestone, MD, JD and
Associates in the amount of $17,309.03; and
b. $550.00, representing petitioners’ costs. The award shall be in the form of a check
made payable to petitioners for $550.00.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment herewith. 2
IT IS SO ORDERED.
Dated: March 7, 2017 s/ Laura D. Millman
Laura D. Millman
Special Master
2
Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or
jointly, filing a notice renouncing the right to seek review.
2